| Bristol Myers Squibb (BMY) |
United States |
$136.042B |
9.43 |
| Amgen (AMGN) |
United States |
$134.261B |
14.00 |
| CSL (CSLLY) |
Australia |
$96.737B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$79.825B |
8.98 |
| Illumina (ILMN) |
United States |
$67.776B |
103.23 |
| Moderna (MRNA) |
United States |
$59.424B |
0.00 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$56.266B |
23.92 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$50.141B |
16.39 |
| Biogen (BIIB) |
United States |
$42.514B |
8.50 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$33.621B |
13.09 |
| BeiGene (BGNE) |
Cayman Islands |
$30.413B |
0.00 |
| Seagen (SGEN) |
United States |
$28.448B |
48.77 |
| BioNTech SE (BNTX) |
Germany |
$26.961B |
0.00 |
| Genmab (GMAB) |
Denmark |
$24.055B |
28.45 |
| Exact Sciences (EXAS) |
United States |
$23.455B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$21.894B |
5.04 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$20.110B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$19.836B |
63.15 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$18.601B |
26.59 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$17.926B |
0.00 |
| Incyte (INCY) |
United States |
$17.372B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$16.360B |
0.00 |
| Guardant Health (GH) |
United States |
$16.011B |
0.00 |
| Novavax (NVAX) |
United States |
$15.484B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.913B |
98.98 |
| Bio-Techne Corp (TECH) |
United States |
$14.622B |
83.75 |
| QIAGEN (QGEN) |
Netherlands |
$12.171B |
24.86 |
| Repligen (RGEN) |
United States |
$10.866B |
154.11 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$10.206B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$10.103B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$9.388B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$8.330B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$8.280B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$8.167B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$8.134B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$7.908B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$7.763B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$7.753B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.931B |
63.47 |
| Sarepta Therapeutics (SRPT) |
United States |
$6.614B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$6.581B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$6.382B |
52.46 |
| NeoGenomics (NEO) |
United States |
$5.883B |
1766.33 |
| Blueprint Medicines (BPMC) |
United States |
$5.648B |
18.60 |
| Beam Therapeutics (BEAM) |
United States |
$5.593B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$5.585B |
0.00 |
| Certara (CERT) |
United States |
$5.547B |
0.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.025B |
15.80 |
| Emergent Biosolutions (EBS) |
United States |
$4.983B |
11.91 |
| China Biologic Products (CBPO) |
China |
$4.715B |
30.56 |
| Arena Pharmaceuticals (ARNA) |
United States |
$4.453B |
0.00 |
| I-Mab (IMAB) |
China |
$4.137B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$4.131B |
0.00 |
| Insmed (INSM) |
United States |
$4.002B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$3.756B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$3.666B |
0.00 |
| Arvinas (ARVN) |
United States |
$3.596B |
0.00 |
| NantKwest (NK) |
United States |
$3.529B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.405B |
123.24 |
| Alkermes (ALKS) |
Ireland |
$3.129B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$3.117B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$3.081B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$2.968B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.957B |
0.00 |
| Viela Bio (VIE) |
United States |
$2.904B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.894B |
0.00 |
| Amarin (AMRN) |
Ireland |
$2.811B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$2.526B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.413B |
19.97 |
| PHARMA MAR SA (PHMMF) |
Spain |
$2.401B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.270B |
44.40 |
| Genetron Holdings (GTH) |
China |
$2.262B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.183B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$2.182B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.161B |
0.00 |
| Vericel (VCEL) |
United States |
$2.152B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$2.040B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.947B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$1.921B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.881B |
0.00 |
| Heska (HSKA) |
United States |
$1.858B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.744B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.724B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$1.700B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$1.672B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$1.661B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.648B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.640B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$1.637B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.610B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.566B |
0.00 |
| Precigen (PGEN) |
United States |
$1.534B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.514B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.499B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$1.455B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$1.434B |
0.00 |
| Alector (ALEC) |
United States |
$1.375B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.367B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.330B |
0.00 |
| Codexis (CDXS) |
United States |
$1.314B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$1.305B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$1.299B |
0.00 |
| MannKind (MNKD) |
United States |
$1.228B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$1.211B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.203B |
0.00 |
| Mesoblast (MESO) |
Australia |
$1.188B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.170B |
7.73 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.123B |
0.00 |
| Athenex (ATNX) |
United States |
$1.111B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$1.096B |
0.00 |
| Morphic Holding (MORF) |
United States |
$1.061B |
0.00 |
| MiMedx (MDXG) |
United States |
$1.058B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.057B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.057B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$1.026B |
43.47 |
| Avid Bioservices (CDMO) |
United States |
$1.015B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$1.013B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$1.000B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.984B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.981B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.932B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.928B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.921B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.911B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.902B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.891B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.843B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.841B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.832B |
22.17 |
| VBI Vaccines (VBIV) |
United States |
$0.816B |
0.00 |
| Agenus (AGEN) |
United States |
$0.796B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.793B |
0.00 |
| Pandion Therapeutics (PAND) |
United States |
$0.741B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.732B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.730B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.719B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.711B |
0.00 |
| ALBIREO PHARMA (ALBO) |
United States |
$0.702B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.690B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.666B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.623B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.598B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.596B |
0.00 |
| Geron (GERN) |
United States |
$0.596B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.589B |
0.00 |
| Curis (CRIS) |
United States |
$0.570B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.566B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.565B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.542B |
73.27 |
| AC Immune SA (ACIU) |
Switzerland |
$0.539B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.531B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.530B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.519B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.519B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.516B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.515B |
0.00 |
| Neoleukin Therapeutics (NLTX) |
United States |
$0.515B |
0.00 |
| AMMO (POWW) |
United States |
$0.514B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.509B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.508B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.505B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.474B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.465B |
0.00 |
| Opthea (OPT) |
Australia |
$0.459B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.452B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.449B |
0.00 |
| IBio (IBIO) |
United States |
$0.436B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.433B |
0.00 |
| Athersys (ATHX) |
United States |
$0.431B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.427B |
20.12 |
| Cue Biopharma (CUE) |
United States |
$0.408B |
0.00 |
| Verastem (VSTM) |
United States |
$0.407B |
0.00 |
| XOMA (XOMA) |
United States |
$0.396B |
0.00 |
| Lineage Cell Therapeutics (LCTX) |
United States |
$0.385B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.380B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.370B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.370B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.368B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.363B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.360B |
9.16 |
| Fortress Biotech (FBIO) |
United States |
$0.350B |
0.00 |
| Trevena (TRVN) |
United States |
$0.344B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.344B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.343B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.341B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.336B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.325B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.320B |
0.00 |
| NextCure (NXTC) |
United States |
$0.312B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.302B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.291B |
16.74 |
| PDL BioPharma (PDLI) |
United States |
$0.282B |
0.00 |
| Cerecor (CERC) |
United States |
$0.275B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.274B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.260B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.251B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.249B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.242B |
6.22 |
| Aptinyx (APTX) |
United States |
$0.235B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.234B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.232B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.231B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.228B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.224B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.223B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.207B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.207B |
0.00 |
| VolitionRX (VNRX) |
United States |
$0.205B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.204B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.203B |
0.00 |
| Exicure (XCUR) |
United States |
$0.201B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.197B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.188B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.184B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.184B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.182B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.177B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.175B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.170B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.169B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.169B |
350.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.168B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.163B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.162B |
0.00 |
| Liminal BioSciences (LMNL) |
Canada |
$0.161B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.159B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.152B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.151B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.146B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.144B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.141B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.141B |
0.00 |
| CytRx (CYTR) |
United States |
$0.137B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.136B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.134B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.130B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.130B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.130B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.128B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.124B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.120B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.118B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.115B |
0.00 |
| Ecology Coatings (ABVC) |
United States |
$0.114B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.113B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.109B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.108B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.107B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.105B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.103B |
0.00 |
| Stealth BioTherapeutics (MITO) |
United States |
$0.100B |
45.25 |
| Vascular Biogenics (VBLT) |
Israel |
$0.099B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.098B |
0.00 |
| Adocia (ADOCY) |
France |
$0.092B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.089B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.089B |
0.00 |
| Celsion (CLSN) |
United States |
$0.089B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.084B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.081B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.080B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.078B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.077B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.075B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.073B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.073B |
0.00 |
| ARIDIS PHARMACT (ARDS) |
United States |
$0.068B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.067B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.066B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.061B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.055B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.054B |
0.00 |
| Appili Therapeutics (APLIF) |
Canada |
$0.054B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.054B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.053B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.049B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.048B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.047B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.045B |
0.00 |
| AIkido Pharma (AIKI) |
United States |
$0.044B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.043B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.039B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.038B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.035B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.031B |
0.00 |
| PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.030B |
0.00 |
| Seneca Biopharma (SNCA) |
United States |
$0.025B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.024B |
0.00 |
| ThermoGenesis Holdings (THMO) |
United States |
$0.024B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.022B |
0.00 |
| Timber Pharmaceuticals (TMBR) |
United States |
$0.020B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.018B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.016B |
0.00 |
| Cyclo Therapeutics (CYTH) |
United States |
$0.013B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |
| Zai Lab (ZLAB) |
China |
$0.000B |
0.00 |
